Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study

Clinical trial NCT05197699 · TERMINATED

Trial details

NCT number: NCT05197699
Sponsor: Biogen
Status: TERMINATED
Study type: OBSERVATIONAL

Multiple Sclerosis (MS)

Start date: 2021-07-01
Primary completion: 2023-09-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.